Introduced

Passed Senate

Passed House

Became law

Adjourned sine die. The bill was pending when the session ended, so it did not pass.

Last action · January 16, 2026

To Committee On Committees (S)

Introduced January 16, 2026

Senate

Adjourned Sine Die

2026 Regular Session

SB103

AN ACT relating to prescription drugs.

Amend KRS 304.17A-164 to define terms; prohibit insurers and administrators from requiring insureds to pay cost sharing for a prescription drug that is greater than the cash price; require insurers and administrators to count the amount paid for a covered prescription drug towards the insured's cost-sharing if certain requirements are met; establish requirements for insurers, administrators, and pharmacies for submission of cash price paid by an insured; exempt a state employee health plan from counting…

Drugs and Medicines Education, Higher Effective Dates, Delayed Insurance, Health Pharmacists State Employees Actuarial Analysis Health Benefit Plan Mandate Local Mandate State Employee Health Plan Mandate

Read the full text Kentucky Legislature LegiScan

AI-generated. Always verify with primary sources

Plain-language summary

Beta

This bill changes how health insurance cost-sharing works for prescription drugs. It would prevent insurers from requiring a patient to pay more out-of-pocket for a covered drug than its cash price, and it would require that amounts paid for covered prescription drugs count toward a person's deductible or other cost-sharing limits. The law would apply to most health insurance plans, including coverage for state employees and employees of public universities, and takes effect January 1, 2027. Who it may affect: Kentuckians with health insurance who use prescription drugs, state employees, and employees of public universities and colleges.

Open official bill text (PDF)·Report a problem with the summary